173 related articles for article (PubMed ID: 36133956)
1. The effects of acute exercise and inflammation on immune function in early-stage prostate cancer.
Schauer T; Djurhuus SS; Simonsen C; Brasso K; Christensen JF
Brain Behav Immun Health; 2022 Nov; 25():100508. PubMed ID: 36133956
[TBL] [Abstract][Full Text] [Related]
2. Autologous serum collected 1 h post-exercise enhances natural killer cell cytotoxicity.
Gupta P; Bigley AB; Markofski M; Laughlin M; LaVoy EC
Brain Behav Immun; 2018 Jul; 71():81-92. PubMed ID: 29656052
[TBL] [Abstract][Full Text] [Related]
3. Acute exercise preferentially redeploys NK-cells with a highly-differentiated phenotype and augments cytotoxicity against lymphoma and multiple myeloma target cells.
Bigley AB; Rezvani K; Chew C; Sekine T; Pistillo M; Crucian B; Bollard CM; Simpson RJ
Brain Behav Immun; 2014 Jul; 39():160-71. PubMed ID: 24200514
[TBL] [Abstract][Full Text] [Related]
4. Acute exercise preferentially redeploys NK-cells with a highly-differentiated phenotype and augments cytotoxicity against lymphoma and multiple myeloma target cells. Part II: impact of latent cytomegalovirus infection and catecholamine sensitivity.
Bigley AB; Rezvani K; Pistillo M; Reed J; Agha N; Kunz H; O'Connor DP; Sekine T; Bollard CM; Simpson RJ
Brain Behav Immun; 2015 Oct; 49():59-65. PubMed ID: 25578514
[TBL] [Abstract][Full Text] [Related]
5. Carbohydrate consumption during cycling increases in vitro NK cell responses to IL-2 and IFN-gamma.
McFarlin BK; Flynn MG; Hampton T
Brain Behav Immun; 2007 Feb; 21(2):202-8. PubMed ID: 16889932
[TBL] [Abstract][Full Text] [Related]
6. Carbohydrate intake during endurance exercise increases natural killer cell responsiveness to IL-2.
McFarlin BK; Flynn MG; Stewart LK; Timmerman KL
J Appl Physiol (1985); 2004 Jan; 96(1):271-5. PubMed ID: 12972438
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cell mobilization and egress following acute exercise in men with prostate cancer.
Hanson ED; Sakkal S; Que S; Cho E; Spielmann G; Kadife E; Violet JA; Battaglini CL; Stoner L; Bartlett DB; McConell GK; Hayes A
Exp Physiol; 2020 Sep; 105(9):1524-1539. PubMed ID: 32715550
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Acute Physical Exercise on NK-Cell Cytolytic Activity: A Systematic Review and Meta-Analysis.
Rumpf C; Proschinger S; Schenk A; Bloch W; Lampit A; Javelle F; Zimmer P
Sports Med; 2021 Mar; 51(3):519-530. PubMed ID: 33398798
[TBL] [Abstract][Full Text] [Related]
9. Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy.
Guven H; Gilljam M; Chambers BJ; Ljunggren HG; Christensson B; Kimby E; Dilber MS
Leukemia; 2003 Oct; 17(10):1973-80. PubMed ID: 14513047
[TBL] [Abstract][Full Text] [Related]
10. Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells.
Ohkawa T; Seki S; Dobashi H; Koike Y; Habu Y; Ami K; Hiraide H; Sekine I
Immunology; 2001 Jul; 103(3):281-90. PubMed ID: 11454057
[TBL] [Abstract][Full Text] [Related]
11. Prostate Cancer Peripheral Blood NK Cells Show Enhanced CD9, CD49a, CXCR4, CXCL8, MMP-9 Production and Secrete Monocyte-Recruiting and Polarizing Factors.
Gallazzi M; Baci D; Mortara L; Bosi A; Buono G; Naselli A; Guarneri A; Dehò F; Capogrosso P; Albini A; Noonan DM; Bruno A
Front Immunol; 2020; 11():586126. PubMed ID: 33569050
[TBL] [Abstract][Full Text] [Related]
12. IL-15R alpha-IgG1-Fc enhances IL-2 and IL-15 anti-tumor action through NK and CD8+ T cells proliferation and activation.
Wu Z; Xu Y
J Mol Cell Biol; 2010 Aug; 2(4):217-22. PubMed ID: 20671116
[TBL] [Abstract][Full Text] [Related]
13. Effects of high- vs moderate-intensity exercise on natural killer cell activity.
Nieman DC; Miller AR; Henson DA; Warren BJ; Gusewitch G; Johnson RL; Davis JM; Butterworth DE; Nehlsen-Cannarella SL
Med Sci Sports Exerc; 1993 Oct; 25(10):1126-34. PubMed ID: 8231757
[TBL] [Abstract][Full Text] [Related]
14. Indomethacin inhibits circulating PGE2 and reverses postexercise suppression of natural killer cell activity.
Rhind SG; Gannon GA; Suzui M; Shephard RJ; Shek PN
Am J Physiol; 1999 May; 276(5):R1496-505. PubMed ID: 10233044
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic Function and Cytokine Production of Natural Killer Cells and Natural Killer T-Like Cells in Systemic Lupus Erythematosis Regulation with Interleukin-15.
Lin SJ; Kuo ML; Hsiao HS; Lee PT; Lee WI; Chen JY; Huang JL
Mediators Inflamm; 2019; 2019():4236562. PubMed ID: 31049024
[TBL] [Abstract][Full Text] [Related]
16. The open window of susceptibility to infection after acute exercise in healthy young male elite athletes.
Kakanis MW; Peake J; Brenu EW; Simmonds M; Gray B; Hooper SL; Marshall-Gradisnik SM
Exerc Immunol Rev; 2010; 16():119-37. PubMed ID: 20839496
[TBL] [Abstract][Full Text] [Related]
17. Association of natural killer cell activity with serum IgE.
Kusaka Y; Sato K; Zhang Q; Morita A; Kasahara T; Yanagihara Y
Int Arch Allergy Immunol; 1997 Apr; 112(4):331-5. PubMed ID: 9104787
[TBL] [Abstract][Full Text] [Related]
18. Exercise training to increase tumour natural killer-cell infiltration in men with localised prostate cancer: a randomised controlled trial.
Djurhuus SS; Simonsen C; Toft BG; Thomsen SN; Wielsøe S; Røder MA; Hasselager T; Østergren PB; Jakobsen H; Pedersen BK; Hojman P; Brasso K; Christensen JF
BJU Int; 2023 Jan; 131(1):116-124. PubMed ID: 35753072
[TBL] [Abstract][Full Text] [Related]
19. Phenotype and Function of Activated Natural Killer Cells From Patients With Prostate Cancer: Patient-Dependent Responses to Priming and IL-2 Activation.
Hood SP; Foulds GA; Imrie H; Reeder S; McArdle SEB; Khan M; Pockley AG
Front Immunol; 2018; 9():3169. PubMed ID: 30761160
[No Abstract] [Full Text] [Related]
20. Higher Frequencies of Lymphocytes Expressing the Natural Killer Group 2D Receptor in Patients With Behçet Disease.
Bonacini M; Soriano A; Zerbini A; Calò E; Cimino L; Muratore F; Fontana L; Braglia L; Parmeggiani M; Salvarani C; Croci S
Front Immunol; 2018; 9():2157. PubMed ID: 30319620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
